Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

ClinicalTrials.gov ID: NCT04336722

Public ClinicalTrials.gov record NCT04336722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia Who Have Undergone a Kasai Hepatoportoenterostomy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.

Study identification

NCT ID
NCT04336722
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Albireo, an Ipsen Company
Industry
Enrollment
254 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 111 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2020 (Actual)
Primary completion
Jun 22, 2026 (Actual)
Completion
Jun 22, 2026 (Actual)
Last update posted
Jul 2, 2026

2020 – 2026

United States locations

U.S. sites
30
U.S. states
21
U.S. cities
28
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027 —
Stanford Children's Health Palo Alto California 94304 —
Rady Children's Hospital San Diego California 92123 —
UCSF Benioff Children's Hospital San Francisco San Francisco California 94158 —
Children's Hospital Colorado Aurora Colorado 80045 —
Nemours/Alfred I. duPont Hospital for Children Wilmington Delaware 19803 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
University of Miami Miami Florida 33146 —
Children's Healthcare of Atlanta - Emory University School of Medicine Atlanta Georgia 30322 —
Ann & Robert H. Lurie Children's Hospital Chicago Illinois 60611 —
Indiana University school of Medicine Indianapolis Indiana 46202 —
Johns Hopkins Children's Center Baltimore Maryland 21287 —
Boston Children's Hospital Boston Massachusetts 02115 —
University of Michigan Children's Hospital Ann Arbor Michigan 48109 —
Children's Mercy Hospital Kansas City Missouri 64108 —
Washington University in St. Louis St Louis Missouri 63110 —
NYU Grossman school of Medicine New York New York 10016 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
NewYork-Presbyterian Morgan Stanley Children's Hospital New York New York 10032 —
The Children's Hospital at Montefiore The Bronx New York 10467 —
Duke Central Tower Durham North Carolina 27710 —
Cincinnati Children's Hospital Cincinnati Ohio 45229 —
Cleveland Clinic Cleveland Ohio 44195 —
Oregon Health & Science University Portland Oregon 97239 —
The Children´s Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
UT Southwestern Medical Center Dallas Texas 75390 —
University of Utah Salt Lake City Utah 84113 —
Seattle Children's Hospital Seattle Washington 98105 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04336722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04336722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →